Undervalued Blue-Chip Stocks to Buy and Hold in 2026: Microsoft and Bristol-Myers Squibb

Two undervalued blue-chip stocks to buy and hold in 2026 are Microsoft and Bristol-Myers Squibb. Microsoft has a wide economic moat and strong financial health, with a 5-year revenue growth rate of 13%. Bristol-Myers Squibb has a strong portfolio of drugs and a robust pipeline, with a focus on areas like immunology, oncology, and rare diseases. Both companies are considered less risky due to their financial stability and are worth buying and holding.